MediSense Optium / Precision Blood Glucose Test Tapes Monitoring System. Parts No. 99134-15; Lots # 50111, 50113, 50123 Valid until September 30, 2002. 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Abbott Laboratories MediSense Products; MediSense Contract Mfg 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    394
  • 날짜
    2002-02-25
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    UNTIL THIS DATE DOES NOT CONSERT PRODUCT REGISTRATION IN BRAZIL
  • 원인
    The calibrator, the white bar, had incorrect programming for glucose tapes for the tests above. if the affected calibrator is used, the medisense optium / pecision extra blood glucose monitor will prompt the message "cal error", followed by a "313" or "316" error code, and the monitor will not calibrate correctly. the distributor declares that the problem does not influence the customer's safety outcome, and that they are taking appropriate corrective and preventive actions to prevent replication. the distributor initiated a correction by letter dated october 2, 2001.
  • 조치
    Verify that you received the letter dated October 2, 2001, return form, sample letter Abbott MediSense. The distributor declares that it is important to calibrate the monitor with each new test cassette box. Identify and isolate any affected product in your inventory. Use the response form to confirm your current inventory, and return the form to your local Abbott Laboratories representative. Upon receipt of the form, you will receive credit for your inventory and MediSense Accounts, Sales and Services representatives will contact you to arrange for the return of the affected product. Notify any customer who has purchased affected lots with this fix; the Abbott MediSense sample letter can be used for this. For more information, contact your local Abbott MediSense representative. For further information, please contact ANVISA's Tecnovigilância Unit, by e-mail tecnovigilancia@anvisa.gov.br or by telephone (61) 448-1485.